Related Experiment Video
Updated: Jul 10, 2025

11:37
Zika Virus Specific Diagnostic Epitope Discovery
Published on: December 12, 2017
7.8K
Immunoinformatics study to explore dengue (DENV-1) proteome to design multi-epitope vaccine construct by using CD4+
1Department of Biotechnology, Faculty of Engineering and Technology Rama University, G.T. Road, Kanpur, 209217, India.
Journal, Genetic Engineering & Biotechnology
|November 21, 2023
Summary
Immunoinformatics approaches were used to design a multi-epitope dengue vaccine construct. This novel vaccine construct demonstrated a stable interaction with TLR5, indicating potential immunogenic effects for treating dengue virus infections.
Area of Science:
- Immunoinformatics
- Computational Biology
- Vaccinology
Background:
- Immunoinformatics integrates immunology, bioinformatics, and computational biology to study the immune system.
- Dengue virus (DENV) poses a significant global health challenge, necessitating innovative vaccine development strategies.
Purpose of the Study:
- To apply immunoinformatics tools for the rational design of a multi-epitope vaccine against dengue.
- To identify and characterize potential epitopes from the dengue proteome for vaccine construction.
Main Methods:
- Utilized immunoinformatics databases and algorithms for epitope prediction.
- Employed bioinformatics approaches to select optimal epitopes.
- Applied molecular modeling to construct a multi-epitope vaccine candidate.
- Performed molecular docking simulations to assess vaccine-host interactions.
Main Results:
- Identified four potent CD4+ T-cell epitopes: NLKYSVIVTVHTGDQ, ANPIVTDKEKPVNIE, LDPVVYDAKFEKQL, and VGAIALDFKPGTSGS.
- The designed multi-epitope vaccine construct exhibited stable docking interactions with Toll-like receptor 5 (TLR5).
- Root Mean Square Deviation (RMSD) values indicated a stable complex formation between the vaccine construct and TLR5, suggesting potential immunogenicity.
Conclusions:
- Immunoinformatics serves as a powerful platform for the design of vaccines against infectious diseases like dengue.
- The developed multi-epitope vaccine construct shows promise as a potential therapeutic intervention for Dengue virus infections.
- This study provides a proof of concept for immunoinformatics-driven vaccine design against DENV.

